Salveen Richter
Stock Analyst at Goldman Sachs
(3.04)
# 1,360
Out of 4,711 analysts
192
Total ratings
41.67%
Success rate
0.6%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Downgrades: Neutral | $36 | $33.21 | +8.40% | 7 | Dec 17, 2024 | |
| QURE uniQure | Maintains: Neutral | $9 → $20 | $16.98 | +17.79% | 7 | Dec 12, 2024 | |
| GILD Gilead Sciences | Maintains: Neutral | $74 → $84 | $92.57 | -9.26% | 4 | Nov 7, 2024 | |
| INCY Incyte | Maintains: Neutral | $63 → $70 | $68.84 | +1.69% | 9 | Oct 30, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Neutral | $31 → $20 | $12.18 | +64.20% | 7 | Oct 25, 2024 | |
| MRNA Moderna | Maintains: Buy | $178 → $139 | $39.39 | +252.88% | 8 | Sep 16, 2024 | |
| RLAY Relay Therapeutics | Reinstates: Buy | $20 | $4.16 | +380.77% | 2 | Sep 10, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $198 → $370 | $245.44 | +50.75% | 5 | Aug 16, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $67 → $76 | $44.22 | +71.87% | 3 | Aug 2, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Sell | $33 → $37 | $35.63 | +3.85% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $5.61 | +96.08% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $35.42 | +49.63% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $50 | $21.45 | +133.10% | 4 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $5 | $6.39 | -21.75% | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $263.38 | +32.89% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $81 | $6.31 | +1,183.68% | 3 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $397.27 | +40.71% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $5 | $3.14 | +59.24% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $17.16 | -70.86% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $188 → $215 | $118.97 | +80.72% | 3 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $9.80 | +12.24% | 1 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.87 | +1,557.75% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $298.12 | -24.53% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $2.90 | +658.62% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.61 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.72 | +535.59% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $14 | $0.96 | +1,361.53% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $6.03 | +49.25% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $1.85 | +62.16% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $16.87 | -28.87% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $1.65 | +263.64% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $62.76 | -31.49% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $370 | $146.47 | +152.61% | 2 | Oct 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $796 → $970 | $701.85 | +38.21% | 9 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $40 → $60 | $8.50 | +605.88% | 6 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $4 | $0.84 | +377.95% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $52 → $46 | $40.72 | +12.97% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.64 | +21.95% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $11.40 | +777.19% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $28 | $15.50 | +80.65% | 2 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.66 | +4,445.45% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $105.32 | -52.53% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $19.45 | +131.36% | 1 | Mar 17, 2020 |
Apellis Pharmaceuticals
Dec 17, 2024
Downgrades: Neutral
Price Target: $36
Current: $33.21
Upside: +8.40%
uniQure
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $16.98
Upside: +17.79%
Gilead Sciences
Nov 7, 2024
Maintains: Neutral
Price Target: $74 → $84
Current: $92.57
Upside: -9.26%
Incyte
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $68.84
Upside: +1.69%
Intellia Therapeutics
Oct 25, 2024
Maintains: Neutral
Price Target: $31 → $20
Current: $12.18
Upside: +64.20%
Moderna
Sep 16, 2024
Maintains: Buy
Price Target: $178 → $139
Current: $39.39
Upside: +252.88%
Relay Therapeutics
Sep 10, 2024
Reinstates: Buy
Price Target: $20
Current: $4.16
Upside: +380.77%
Alnylam Pharmaceuticals
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $245.44
Upside: +50.75%
Ultragenyx Pharmaceutical
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $44.22
Upside: +71.87%
Ionis Pharmaceuticals
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $35.63
Upside: +3.85%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $5.61
Upside: +96.08%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $35.42
Upside: +49.63%
Feb 29, 2024
Maintains: Buy
Price Target: $73 → $50
Current: $21.45
Upside: +133.10%
Feb 16, 2024
Maintains: Neutral
Price Target: $11 → $5
Current: $6.39
Upside: -21.75%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $263.38
Upside: +32.89%
Feb 7, 2024
Reinstates: Buy
Price Target: $81
Current: $6.31
Upside: +1,183.68%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $397.27
Upside: +40.71%
Sep 13, 2023
Downgrades: Neutral
Price Target: $5
Current: $3.14
Upside: +59.24%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $17.16
Upside: -70.86%
Jun 23, 2023
Maintains: Buy
Price Target: $188 → $215
Current: $118.97
Upside: +80.72%
Mar 2, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $9.80
Upside: +12.24%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.87
Upside: +1,557.75%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $298.12
Upside: -24.53%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $2.90
Upside: +658.62%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.61
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.72
Upside: +535.59%
Nov 10, 2022
Maintains: Buy
Price Target: $25 → $14
Current: $0.96
Upside: +1,361.53%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $6.03
Upside: +49.25%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $1.85
Upside: +62.16%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $16.87
Upside: -28.87%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $1.65
Upside: +263.64%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $62.76
Upside: -31.49%
Oct 26, 2022
Upgrades: Buy
Price Target: $370
Current: $146.47
Upside: +152.61%
Oct 3, 2022
Maintains: Buy
Price Target: $796 → $970
Current: $701.85
Upside: +38.21%
Aug 19, 2022
Maintains: Sell
Price Target: $40 → $60
Current: $8.50
Upside: +605.88%
May 24, 2022
Maintains: Neutral
Price Target: $7 → $4
Current: $0.84
Upside: +377.95%
May 24, 2022
Maintains: Neutral
Price Target: $52 → $46
Current: $40.72
Upside: +12.97%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.64
Upside: +21.95%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $11.40
Upside: +777.19%
May 12, 2022
Maintains: Neutral
Price Target: $48 → $28
Current: $15.50
Upside: +80.65%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.66
Upside: +4,445.45%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $105.32
Upside: -52.53%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $19.45
Upside: +131.36%